API
< Back to situation

[REVISION HISTORY]

Portugal seasonal influenza and COVID-19 vaccination

8 recorded revisions of this situation.

What changed

2026-11-09 19:02 UTC → 2026-11-17 02:04 UTC · added removed

Portugal's 2026-2027 seasonal influenza and COVID-19 vaccination campaign, running from September 30, 2026, to March 31, 2027, has seen a notable increase in uptake through community pharmacies. By late October 2026, the Directorate-General for Health (DGS) reported that over 1.3 million influenza vaccinations had been administered. Of these, 689,106 doses were delivered via pharmacies, while 650,380 were provided through the National Health Service (SNS). Data from the first 19 days of the campaign indicates that community pharmacies administered 520,584 flu vaccines, a 15.1% increase compared to the same period in 2025. This growth outpaced the 1.9% increase recorded in SNS units. When combining influenza and COVID-19 doses, pharmacies accounted for 55.6% of the national total. The Association of Pharmacies of Portugal (AFP) attributed this high uptake to extended hours, weekend availability, and the new VACINAS 2.0 registration platform. In terms of demographics, individuals aged 60 and older represent the largest group, with over 1.1 million doses administered, reaching a 35.2% coverage rate. Other vaccinated groups include approximately 112,000 residents in care facilities, 26,000 healthcare professionals, and 152,000 high-risk individuals. Regarding COVID-19, approximately 600,000 boosters have been delivered, representing a 17.1% coverage rate among those over 60. While influenza uptake in pharmacies rose, COVID-19 vaccinations in these settings decreased by 9.4%. By early November mid-November 2026, the National Association of Pharmacies (ANF) reported confirmed a shortage of flu vaccines intended for the private sector. These doses, purchased by pharmacies for individuals outside the DGS priority groups, dropped from approximately 300,000 in 2025 to 50,000 this year. The ANF attributed this to international factors, including new WHO requirements for vaccine strains and pharmaceutical production issues. Recent analysis indicates stagnation in flu vaccination rates, which remain below the 75% target for individuals aged 65 and older, alongside a declining trend in COVID-19 vaccinations. To address these challenges, seven proposed measures have been identified to improve the campaign. These include increasing the lead time for vaccine acquisition, enhancing transparency through national data, and increasing vaccine availability by encouraging prescriptions in hospital sectors. Additional proposals suggest extending the validity of medical prescriptions issued in the second half of the year and increasing co-payment support (comparticipação) for all vaccines, specifically mentioning high-dose flu vaccines and recombinant COVID-19 vaccines.

Versions

  1. 2026-11-17 02:04 UTC Portugal seasonal influenza and COVID-19 vaccination
  2. 2026-11-09 19:02 UTC Portugal seasonal influenza and COVID-19 vaccination
  3. 2026-11-04 21:15 UTC Portugal seasonal influenza and COVID-19 vaccination
  4. 2026-11-03 18:00 UTC Portugal seasonal influenza and COVID-19 vaccination
  5. 2026-10-29 12:28 UTC Portugal seasonal influenza and COVID-19 vaccination
  6. 2026-10-27 18:37 UTC Portugal seasonal influenza and COVID-19 vaccination
  7. 2026-10-10 07:27 UTC Portugal seasonal influenza and COVID-19 vaccination
  8. 2026-09-30 06:09 UTC Portugal seasonal influenza and COVID-19 vaccination
  9. 2026-09-17 17:06 UTC Portugal seasonal influenza and COVID-19 vaccination

Select a version to see what changed compared to the one before it.